Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up.

od de Mascarel, I., Bonichon, F., Coindre, J. M., Trojani, M.
Izdano 1992

Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: detection by immunohistochemistry and prognostic significance.

od Trojani, M., de Mascarel, I., Coindre, J. M., Bonichon, F.
Izdano 1987

Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance.

od Trojani, M., de Mascarel, I., Bonichon, F., Coindre, J. M., Delsol, G.
Izdano 1987

An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue.

od Terrier, P., Townsend, A. J., Coindre, J. M., Triche, T. J., Cowan, K. H.
Izdano 1990

Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.

od Soubeyran, I., Quénel, N., Mauriac, L., Durand, M., Bonichon, F., Coindre J-M
Izdano 1996

Expression of MDR1/P glycoprotein in human sarcomas.

od Vergier, B., Cany, L., Bonnet, F., Robert, J., de Mascarel, A., Coindre, J. M.
Izdano 1993

Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.

od Rudolph, P., Kellner, U., Chassevent, A., Collin, F., Bonichon, F., Parwaresch, R., Coindre, J. M.
Izdano 1997

pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.

od Soubeyran, I., Quénel, N., Coindre, J. M., Bonichon, F., Durand, M., Wafflart, J., Mauriac, L.
Izdano 1996

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

od MacGrogan, G., Mauriac, L., Durand, M., Bonichon, F., Trojani, M., de Mascarel, I., Coindre, J. M.
Izdano 1996

Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials.

od Ravaud, A., Bui, N. B., Coindre, J. M., Lagarde, P., Tramond, P., Bonichon, F., Stöckle, E., Kantor, G., Trojani, M., Chauvergne, J.
Izdano 1992

Clear Cell Sarcoma (Malignant Melanoma) of Soft Parts: A Clinicopathologic Study of 52 Cases

od Hocar, O., Le Cesne, A., Berissi, S., Terrier, P., Bonvalot, S., Vanel, D., Auperin, A., Le Pechoux, C., Bui, B., Coindre, J. M., Robert, C.
Izdano 2012

GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study

od Italiano, A., Le Cesne, A., Bellera, C., Piperno-Neumann, S., Duffaud, F., Penel, N., Cassier, P., Domont, J., Takebe, N., Kind, M., Coindre, J.-M., Blay, J.-Y., Bui, B.
Izdano 2013

DNA topoisomerase IIα expression and the response toprimary chemotherapy in breast cancer

od MacGrogan, G, Rudolph, P, Mascarel, I de, Mauriac, L, Durand, M, Avril, A, Dilhuydy, J M, Robert, J, Mathoulin-Pélissier, S, Picot, V, Floquet, A, Sierankowski, G, Coindre, J M
Izdano 2003

Prognosis and predictive value of KIT exon 11 deletion in GISTs

od Bachet, J-B, Hostein, I, Le Cesne, A, Brahimi, S, Beauchet, A, Tabone-Eglinger, S, Subra, F, Bui, B, Duffaud, F, Terrier, P, Coindre, J-M, Blay, J-Y, Emile, J-F
Izdano 2009

Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)

od Bugat, R, Bataillard, A, Lesimple, T, Voigt, J J, Culine, S, Lortholary, A, Merrouche, Y, Ganem, G, Kaminsky, M C, Negrier, S, Perol, M, Laforêt, C, Bedossa, P, Bertrand, G, Coindre, J M, Fizazi, K
Izdano 2003

Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas

od Brahmi, M., Lesluyes, T., Dufresne, A., Toulmonde, M., Italiano, A., Mir, O., Le Cesne, A., Valentin, T., Chevreau, C., Bonvalot, S., Penel, N., Coindre, J.-M., Le Guellec, S., Le Loarer, F., Karanian, M., Blay, J.-Y., Chibon, F.
Izdano u ESMO Open (2021)

High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management

od Dômont, J, Salas, S, Lacroix, L, Brouste, V, Saulnier, P, Terrier, P, Ranchère, D, Neuville, A, Leroux, A, Guillou, L, Sciot, R, Collin, F, Dufresne, A, Blay, J-Y, Le Cesne, A, Coindre, J-M, Bonvalot, S, Bénard, J
Izdano 2010

Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions

od Ray-Coquard, I., Montesco, M. C., Coindre, J. M., Dei Tos, A. P., Lurkin, A., Ranchère-Vince, D., Vecchiato, A., Decouvelaere, A. V., Mathoulin-Pélissier, S., Albert, S., Cousin, P., Cellier, D., Toffolatti, L., Rossi, C. R., Blay, J. Y.
Izdano 2012

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma

od Dufresne, A., Lesluyes, T., Ménétrier-Caux, C., Brahmi, M., Darbo, E., Toulmonde, M., Italiano, A., Mir, O., Le Cesne, A., Le Guellec, S., Valentin, T., Chevreau, C., Bonvalot, S., Robin, Y.M., Coindre, J-M, Caux, C., Blay, J.Y., Chibon, F.
Izdano u Oncoimmunology (2020)

Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study(†)

od Mathoulin-Pélissier, S., Chevreau, C., Bellera, C., Bauvin, E., Savès, M., Grosclaude, P., Albert, S., Goddard, J., Le Guellec, S., Delannes, M., Bui, B. N., Mendiboure, J., Stoeckle, E., Coindre, J. M., Kantor, G., Kind, M., Cowppli-Bony, A., Hoppe, S., Italiano, A.
Izdano 2014